NCT00019682 2017-11-20Aldesleukin With or Without Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic MelanomaNational Cancer Institute (NCI)Phase 3 Completed185 enrolled 11 charts
NCT00094653 2011-07-11MDX-010 Antibody, MDX-1379 Melanoma Vaccine, or MDX-010/MDX-1379 Combination Treatment for Patients With Unresectable or Metastatic MelanomaBristol-Myers SquibbPhase 3 Completed1,783 enrolled 29 charts